Safety evaluation and optimization of high-efficiency expression of 5hsCT in Saccharomyces cerevisiae
Biotechnology Letters · 2025
DOI: 10.1007/s10529-025-03607-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Letters, 2025. Verfasst von Yakun Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioscience and Technology, Shandong Second Medical University, 7166 Baotong West Street, Weifang, 261053, Shandong, China. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Recombinant Proteins, Calcitonin. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Development Program for Youth Innovation Team in Colleges and Universities of Shandong Province.
Abstract (Originalsprache)
To evaluate the oral safety of the industrial strain Saccharomyces cerevisiae YS-5hsCT (S. cerevisiae YS-5hsCT) expressing human/salmon chimeric calcitonin (5hsCT) and optimize its fermentation conditions, providing scientific basis for industrial production of oral recombinant calcitonin. The strain demonstrated an LD50 > 10 g kg⁻1, with all toxicological tests yielding negative results and normal hematological/biochemical parameters (P > 0.05). mRNA analysis revealed optimal gene expression at 96 h, 30 °C and 225 rpm. Single-factor experiments established optimal growth conditions: 8% initial inoculum size, 72 h culture, 30 °C, 200-250 rpm agitation, and 7-8.5 l min⁻1 aeration. Under optimized conditions (10% inoculum size, 72 h, 25 °C, 225 rpm, 7 l min⁻1 aeration), the biomass reached 7.175 g l⁻1 d⁻1 and the 5hsCT protein yield was 149.24 mg l⁻1 d⁻1. These findings confirm the oral safety of YS-5hsCT and providetechnical support for industrial calcitonin production. Safety evaluations demonstrated transgenic S. cerevisiae YS-5hsCT exhibits no toxicity or mutagenicity, with optimized cultivation conditions enhancing biomass yield for potential calcitonin production applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Bioscience and Technology, Shandong Second Medical University, 7166 Baotong West Street, Weifang, 261053, Shandong, China.
- School of Bioscience and Technology, Shandong Second Medical University, 7166 Baotong West Street, Weifang, 261053, Shandong, China. sunhengyi1987@sdsmu.edu.cn.
- The Shandong Engineering Research Center for Biological Drug Development and Application, Shandong, China. sunhengyi1987@sdsmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Development Program for Youth Innovation Team in Colleges and Universities of Shandong Province
Zitieren
APA
Zhang, Y., Jia, W., Qiu, W., Tang, Y., Wei, H., & Sun, H. (2025). Safety evaluation and optimization of high-efficiency expression of 5hsCT in Saccharomyces cerevisiae. Biotechnology Letters. https://doi.org/10.1007/s10529-025-03607-2
Vancouver
Zhang Y, Jia W, Qiu W, Tang Y, Wei H, Sun H. Safety evaluation and optimization of high-efficiency expression of 5hsCT in Saccharomyces cerevisiae. Biotechnology Letters. 2025. doi:10.1007/s10529-025-03607-2
BibTeX
@article{Zhang2025,
author = {Zhang, Yakun and Jia, Wenlu and Qiu, Wenli and Tang, Yujing and Wei, Hualin and Sun, Hengyi},
title = {Safety evaluation and optimization of high-efficiency expression of 5hsCT in Saccharomyces cerevisiae},
journal = {Biotechnology Letters},
year = {2025},
doi = {10.1007/s10529-025-03607-2}
}
EUVIMED